FDA Clears Blood Test for Colorectal Cancer Screening in Average-Risk Adults

The FDA has approved SimpleScreen CRC (Freenome), a new blood-based screening test for colorectal cancer (CRC) in adults aged 45 and older who are at average risk. This test identifies signals associated with CRC from cell-free DNA in blood samples. The approval provides a less invasive and potentially more accessible screening option, which could improve early detection rates for colorectal cancer.